AI-Based Analytics for Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease (COPD) is a major cause of global morbidity and mortality, characterized by progressive airflow limitation and frequent exacerbations. Early detection, accurate diagnosis, and effective management are critical to improving patient outcomes and reducing healthcare costs. Traditional methods of diagnosis and monitoring have limitations, especially in the context of the disease's complex, heterogeneous nature. This paper explores the role of Artificial Intelligence (AI) in enhancing COPD management through data-driven analytics. It examines how AI-based techniques, including machine learning (ML), deep learning (DL), and natural language processing (NLP), can be leveraged to predict exacerbations, personalize treatment plans, and monitor disease progression in real-time. The paper also discusses various data sources, including electronic health records (EHRs), wearable devices, and imaging, and highlights the importance of effective data preprocessing. Real-world case studies and clinical implementations demonstrate the effectiveness of AI models in predicting acute events and improving patient outcomes. Ethical, legal, and practical considerations, such as data privacy, model transparency, and integration into clinical workflows, are also addressed. The paper concludes with a discussion of future directions, including multimodal data integration, continuous learning systems, and remote monitoring technologies. AI-based analytics hold the potential to revolutionize COPD care, offering a more personalized, efficient, and proactive approach to managing this chronic disease.